Top of this page
Skip navigation, go straight to the content
Newsroom
•
Press Releases
Search Press releases
![Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira[®]](/_up/ucb_com_presscenter/images/presscenter_teaser_23.jpg?300)
06 Dec 2019
Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira …
Read more
15 Nov 2019
Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study …
Read more
08 Nov 2019
Transparency notifications BlackRock, Inc.
Read more
08 Nov 2019
UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs …
Read more
18 Oct 2019
Transparency notification Vanguard Health Care Fund
Read more
18 Oct 2019
EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of …
Read more
Stay up-to-date on the latest news and information from UCB